iPSC-sEVs alleviate microglia senescence to protect against ischemic stroke in aged mice

Xinyu Niu1, Yuguo Xia2, Lei Luo3

  • 1Department of Neurosurgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.

Materials Today. Bio
|March 20, 2023
PubMed

Insights

Inducible pluripotent stem cell-derived small extracellular vesicles (iPSC-sEVs) reverse microglia aging in stroke. This therapy reduces inflammation and improves outcomes in aged mice, offering a novel treatment for aged ischemic stroke.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cellular Biology

Background:

  • Microglia polarization significantly impacts ischemic stroke (IS) outcomes.
  • Senescent microglia in aged individuals exhibit a pro-inflammatory phenotype, worsening IS outcomes.
  • Inducible pluripotent stem cell-derived small extracellular vesicles (iPSC-sEVs) demonstrate anti-aging properties.

Purpose of the Study:

  • To investigate if iPSC-sEVs can alleviate microglia senescence and modulate polarization in aged ischemic stroke.
  • To explore the therapeutic potential of iPSC-sEVs for aged ischemic stroke.

Main Methods:

  • Treatment of aged mice and cell cultures with iPSC-sEVs.
  • Assessment of microglia senescence markers (P16, P21, P53, γ-H2AX, SA-β-gal activity).
  • Analysis of microglia polarization (pro-inflammatory vs. anti-inflammatory phenotypes).
  • Investigation of the Rictor/AKT signaling pathway and transforming growth factor-β1 (TGF-β1) involvement.
  • Evaluation of neuronal apoptosis and stroke outcomes in mice.

Main Results:

  • iPSC-sEV treatment significantly reduced microglia senescence markers and inhibited pro-inflammatory activation.
  • iPSC-sEVs shifted microglia polarization towards an anti-inflammatory phenotype, decreasing neuronal apoptosis.
  • The therapy improved outcomes in aged stroke mice by upregulating Rictor and p-AKT (s473) via TGF-β1 delivery.
  • Inhibition of Rictor abolished the beneficial effects of iPSC-sEVs on microglia.

Conclusions:

  • iPSC-sEVs effectively reverse microglia senescence and pro-inflammatory characteristics in aged brains.
  • The therapeutic mechanism involves TGF-β1 delivery by iPSC-sEVs to upregulate Rictor and p-AKT signaling.
  • iPSC-sEVs represent a promising therapeutic strategy for aged ischemic stroke and related conditions.